Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (32) Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (36) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Fischer, Cornelius Dr. (1) Gerhardt, Holger Prof. Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (7) Kühn, Ralf Dr. (1) Kunz, Severine Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Poncette, Lucia (1) Quedenau, Claudia (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Walther, Wolfgang Prof. Dr. (1) (-) Bunse, Mario Dr. (1) (-) Kopp, Joachim Dr. (1) (-) Willimsky, Gerald Dr. (9) Bioinformatics and Omics Data Science (1) Bioinformatik der Genregulation (1) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Epigenetische Regulation und Chromatinstruktur (1) Experimentelle Ultrahochfeld-MR (4) Genetik metabolischer und reproduktiver Störungen (2) Genetik und Genomik von Herz- Kreislauferkrankungen (3) Immunregulation und Krebs (1) Kardiale MRT (1) Magnetic Resonance (4) Mobile DNA (1) (-) Molekulare Immunologie und Gentherapie (10) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (1) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (5) Systembiologie von Gen-regulatorischen Elementen (2) Zelluläre Neurowissenschaften (2) 1997 (1) (-) 1998 (1) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) 2008 (2) 2010 (4) 2011 (1) 2012 (1) (-) 2013 (5) 2015 (3) 2016 (1) (-) 2017 (1) 2018 (5) 2019 (3) 2020 (2) 2021 (2) 2022 (8) 2023 (8) 2024 (1) 10 Ergebnisse: Active Filter: Bunse, Mario Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.Molekulare Immunologie und Gentherapie 19982002200720132017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein 01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder 01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen 01. Februar 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen
01. Februar 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem